Review maps CBD's multi-target anti-cancer effects from lab bench to early clinical evidence
CBD shows anti-proliferative, pro-apoptotic, anti-invasive, and anti-inflammatory properties across multiple cancer types in laboratory and animal studies, with early clinical evidence emerging.
Quick Facts
What This Study Found
The review documents CBD's effects against cancer through multiple mechanisms: inhibiting cell proliferation, promoting cancer cell death, blocking invasion and angiogenesis, and modulating inflammation and immune responses. These effects have been observed in breast, lung, colon, prostate, glioblastoma, and other cancer types.
Key Numbers
Over 100 phytocannabinoids have been detected in Cannabis sativa. CBD showed effects across at least six distinct anti-cancer mechanisms (anti-proliferative, pro-apoptotic, cytotoxic, anti-invasive, anti-angiogenic, and immunomodulatory).
How They Did This
Comprehensive review of in vitro cell studies, in vivo animal models, and available clinical data on CBD's anticancer properties, covering mechanisms of action and pharmacological profile.
Why This Research Matters
Cancer patients frequently ask about CBD. This review consolidates the mechanistic evidence showing CBD acts through multiple pathways, while also noting the significant gap between laboratory findings and clinical proof.
The Bigger Picture
CBD's advantage over THC for cancer research is its lack of psychoactive effects, making clinical applications more practical. The multi-target nature of CBD is unusual and could make it valuable as an adjunct therapy, though clinical trials remain limited.
What This Study Doesn't Tell Us
Most evidence comes from cell cultures and animal models. Clinical data is scarce. Doses used in laboratory studies may not be achievable in humans. CBD's bioavailability challenges are acknowledged but not resolved.
Questions This Raises
- ?Can the anti-cancer concentrations of CBD achieved in lab dishes be replicated in human tumors?
- ?Which cancer types are most likely to benefit from CBD-based therapies?
Trust & Context
- Key Stat:
- 6+ anti-cancer mechanisms
- Evidence Grade:
- Moderate: comprehensive review covering multiple study types, but limited by scarce clinical data.
- Study Age:
- Published in 2019.
- Original Title:
- Cannabidiol-from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer.
- Published In:
- International journal of molecular sciences, 20(23) (2019)
- Authors:
- Kis, Brigitta, Ifrim, Feng Chen, Buda, Valentina, Avram, Stefana, Pavel, Ioana Zinuca, Antal, Diana, Paunescu, Virgil, Dehelean, Cristina Adriana, Ardelean, Florina, Diaconeasa, Zorita, Soica, Codruta, Danciu, Corina
- Database ID:
- RTHC-02109
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Can CBD cure cancer?
Laboratory and animal studies show CBD has anti-cancer properties through multiple mechanisms, but clinical evidence in humans is still very limited.
What types of cancer has CBD been studied for?
Lab studies have examined CBD in breast, lung, colon, prostate, glioblastoma, and several other cancer types, though most data comes from cell cultures rather than clinical trials.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-02109APA
Kis, Brigitta; Ifrim, Feng Chen; Buda, Valentina; Avram, Stefana; Pavel, Ioana Zinuca; Antal, Diana; Paunescu, Virgil; Dehelean, Cristina Adriana; Ardelean, Florina; Diaconeasa, Zorita; Soica, Codruta; Danciu, Corina. (2019). Cannabidiol-from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer.. International journal of molecular sciences, 20(23). https://doi.org/10.3390/ijms20235905
MLA
Kis, Brigitta, et al. "Cannabidiol-from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer.." International journal of molecular sciences, 2019. https://doi.org/10.3390/ijms20235905
RethinkTHC
RethinkTHC Research Database. "Cannabidiol-from Plant to Human Body: A Promising Bioactive ..." RTHC-02109. Retrieved from https://rethinkthc.com/research/kis-2019-cannabidiolfrom-plant-to-human
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.